Abstract |
In tumors, vascular endothelial growth factor ( VEGF) contributes to angiogenesis, vascular permeability, and tumorigenesis. In our previous study, we found that α- solanine, which is widespread in solanaceae, has a strong anti- cancer effect under normoxia. However, it is unknown whether α- solanine has a similar effect under hypoxia. We used cobalt chloride (CoCl2) to mimic hypoxia in vitro. HIF-1α, which is almost undetectable under normoxia, was significantly increased. Simultaneously, another regulator of VEGF, STAT3, was also significantly activated by CoCl2. We utilized α- solanine in co-culture with CoCl2. α- solanine decreased the expression of VEGF and loss of E-cadherin. α- solanine also suppressed the activation of phospho-ERK1/2 (p-ERK1/2), HIF-1α, and STAT3 signaling. The results provide new evidence that α- solanine has a strong anti- cancer effect via the ERK1/2-HIF-1α and STAT3 signaling pathways and suggest that it may be a potential new drug.
|
Authors | Zhengde Wen, Chaohao Huang, Yaya Xu, Yuwu Xiao, Lili Tang, Juji Dai, Hongwei Sun, Bicheng Chen, Mengtao Zhou |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 771
Pg. 93-8
(Jan 15 2016)
ISSN: 1879-0712 [Electronic] Netherlands |
PMID | 26688571
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier B.V. All rights reserved. |
Chemical References |
- Cadherins
- Hypoxia-Inducible Factor 1
- STAT3 Transcription Factor
- STAT3 protein, human
- Vascular Endothelial Growth Factor A
- alpha-solanine
- Solanine
- Cobalt
- cobaltous chloride
|
Topics |
- Cadherins
(biosynthesis, genetics)
- Cell Line, Tumor
- Cobalt
(pharmacology)
- Coculture Techniques
- Down-Regulation
- Humans
- Hypoxia-Inducible Factor 1
(biosynthesis, genetics)
- MAP Kinase Signaling System
(drug effects)
- Pancreatic Neoplasms
(drug therapy, genetics)
- STAT3 Transcription Factor
(drug effects)
- Signal Transduction
(drug effects)
- Solanine
(pharmacology)
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors, biosynthesis)
|